We are proud to share that in the recently released 2025 World’s Top 2% Scientists List by Stanford University and Elsevier, 26 members of the Ferroptosis and Oxidative Stress (FOS) Editorial Board have been selected for the Single-Year Impact list (84% of the Board), while 18 members have been recognized in the Career-Long Impact list (58% of the Board).

On September 19, 2025, Stanford University in collaboration with Elsevier officially released the global ranking. The list is based on citation data from the Scopus database and evaluated by six core indicators, including total citations, Hirsch H-index, Schreiber Hm-index (co-authorship adjusted), and citation counts for single-authored and first/last/corresponding-authored papers. The ranking is divided into two categories:
• Career-Long Impact (overall scientific influence across a scholar’s career)
• Single-Year Impact (scientific influence during 2024)

Covering nearly 7 million scientists worldwide, the evaluation spans 22 scientific fields and 174 subfields, providing an objective benchmark for both long-term academic achievement and annual research performance.

This outstanding recognition highlights the remarkable research contributions and global leadership of our editors in advancing ferroptosis, oxidative stress, and related biomedical sciences. Their inclusion reflects both the strength of the FOS editorial team and the journal’s commitment to excellence in publishing high-impact research.

We extend our warmest congratulations to all Editors who have been named in the 2025 World’s Top 2% Scientists list, and express our heartfelt gratitude for your exceptional contributions to the advancement of science!

Career-long Impact (18 FOS Editors)
Douglas R. Green- St. Jude Children's Research Hospital, USA.
Patrizia Agostinis- KU Leuven, Belgium.
Marcus Conrad- Technical University of Munich, Germany.
Scott J. Dixon- Stanford University, USA.
Boyi Gan- The University of Texas MD Anderson Cancer Center, USA.
Xuejun Jiang- Memorial Sloan-Kettering Cancer Center, USA.
Valerian E. Kagan- University of Pittsburgh, USA.
Andreas Linkermann- University of Heidelberg, Germany.
Tak Mak- University of Toronto, Canada.
Seamus Martin- Trinity College, Ireland.
Hozumi Motohashi- Trinity College, Ireland.
Peter Vandenabeele- Ghent University, Belgium.
James A. Olzmann- University of California, USA.
Rachid Skouta- University of Massachusetts, USA.
Brent R. Stockwell- Columbia University, New York, USA.
Shinya Toyokuni- Nagoya University Graduate School of Medicine, Japan.
Karen Vousden- The Francis Crick Institute, UK.
Weiping Zou- University of Michigan Rogel Cancer Center, USA.

Single-year Impact (26 FOS Editors)
Douglas R. Green- St. Jude Children's Research Hospital, USA.
Patrizia Agostinis- KU Leuven, Belgium.
Scott Ayton- The Florey Institute of Neuroscience and Mental Health, Australia.
Marcus Conrad- Technical University of Munich, Germany.
Gina M. DeNicola- H. Lee Moffitt Cancer Center and Research Institute, USA.
Scott J. Dixon- Stanford University, USA.
Boyi Gan- The University of Texas MD Anderson Cancer Center, USA.
Xuejun Jiang- Memorial Sloan-Kettering Cancer Center, USA.
Valerian E. Kagan- University of Pittsburgh, USA.
Richard N. Kitsis- Albert Einstein College of Medicine, USA.
Andreas Linkermann- University of Heidelberg, Germany.
Tak Mak- University of Toronto, Canada.
Seamus Martin- Trinity College, Ireland.
Junxia Min- Zhejiang University School of Medicine, China.
Hozumi Motohashi- Tohoku University Gradate School of Medicine, Japan.
Cristina Muñoz-Pinedo- Bellvitge Biomedical Research Institute L'Hospitalet, Spain.
James A. Olzmann- University of California, USA.
Thales Y. Papagiannakopoulos - New York University School of Medicine, USA.
Rachid Skouta- University of Massachusetts, USA.
Brent R. Stockwell- Columbia University, New York, USA.
Shinya Toyokuni- Nagoya University Graduate School of Medicine, Japan.
Peter Vandenabeele- Ghent University, Belgium.
Karen Vousden- The Francis Crick Institute, UK.
Fudi Wang- Zhejiang University School of Medicine, China.
Qing Zhong- Shanghai Jiao Tong University School of Medicine, China.
Weiping Zou - University of Michigan Rogel Cancer Center, USA.
Note: The above lists are arranged alphabetically by surname, with no ranking implied.

For more information, please refer to the official release to view the Stanford–Elsevier dataset: https://elsevier.digitalcommonsdata.com/datasets/btchxktzyw/8?utm_source=chatgpt.com